» Articles » PMID: 16705122

Effectiveness of Radiation Therapy for Older Women with Early Breast Cancer

Overview
Specialty Oncology
Date 2006 May 18
PMID 16705122
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent clinical trials have questioned the necessity of breast radiation therapy for older women with early breast cancer. However, the effectiveness of radiation therapy for older women in the community setting has not been addressed.

Methods: We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database from January 1, 1992, through December 31, 1999, to identify 8724 women aged 70 years or older treated with conservative surgery for small, lymph node-negative, estrogen receptor-positive (or unknown receptor status) breast cancer. We used a proportional hazards model to test whether radiation therapy was associated with a lower risk of a combined outcome, defined as a second ipsilateral breast cancer reported by SEER and/or a subsequent mastectomy reported by Medicare claims. All statistical tests were two-sided.

Results: Radiation therapy, compared with no radiation therapy, was associated with a lower risk of the combined outcome (hazard ratio = 0.19, 95% confidence interval = 0.14 to 0.28). Radiation therapy was associated with an absolute risk reduction of 4.0 events per 100 women at 5 years (i.e., from 5.1 events without radiation therapy to 1.1 with radiation therapy) and 5.7 events per 100 persons at 8 years (i.e., from 8.0 events without radiation therapy to 2.3 with radiation therapy) (P < .001, log-rank test). Radiation therapy was most likely to benefit those aged 70-79 years without comorbidity (number needed to treat [NNT] to prevent one event = 21 to 22 patients) and was least likely to benefit those aged 80 years or older with moderate to severe comorbidity (NNT = 61 to 125 patients).

Conclusion: For older women with early breast cancer, radiation therapy was associated with a lower risk of a second ipsilateral breast cancer and subsequent mastectomy. Patients aged 70-79 years with minimal comorbidity were the most likely to benefit, and older patients with substantial comorbidity were least likely to benefit.

Citing Articles

Association of Patient Experience of Care and Radiation Therapy Initiation Among Women With Early-Stage Breast Cancer.

Halpern M, McNeel T, Kozono D, Mollica M Pract Radiat Oncol. 2023; 13(5):434-443.

PMID: 37150319 PMC: 10524855. DOI: 10.1016/j.prro.2023.04.011.


Semiparametric copula-based regression modeling of semi-competing risks data.

Zhu H, Lan Y, Ning J, Shen Y Commun Stat Theory Methods. 2022; 51(22):7830-7845.

PMID: 36353187 PMC: 9640177. DOI: 10.1080/03610926.2021.1881122.


Incidence of other cancer diagnoses in women with breast cancer: a retrospective cohort study with 42,248 women.

Nikolov I, Kostev K, Kalder M Breast Cancer Res Treat. 2022; 195(1):75-82.

PMID: 35829934 DOI: 10.1007/s10549-022-06666-5.


Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer.

Moningi S, Lei X, Fang P, Taniguchi C, Holliday E, Koay E Clin Transl Radiat Oncol. 2022; 35:9-16.

PMID: 35510142 PMC: 9058953. DOI: 10.1016/j.ctro.2022.04.007.


Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer.

Ali A, Tawk R, Xiao H, Semykina A, Montero A, Moussa R Expert Rev Pharmacoecon Outcomes Res. 2022; 22(5):735-741.

PMID: 35189767 PMC: 10791147. DOI: 10.1080/14737167.2022.2044309.